{
  "docId": "019dd923-5f69-752d-a9b5-a223ca1fad39",
  "docSlug": "F1L03cpOJK9Pii1lEICW",
  "documentTitle": "We got ahold of the 15-slide presentation that Deep Genomics used to pitch investors led by SoftBank on a new way to discover and develop drugs",
  "authorId": "Pitchdecks",
  "authorName": "Deep Genomics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.775,
  "pageNumber": 13,
  "pageCount": 15,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "traction",
  "function": "show_traction",
  "density": "balanced",
  "nDataPoints": 12,
  "notes": null,
  "elementsJson": [
    "action_title",
    "bar_chart_grouped"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5f69-752d-a9b5-a223ca1fad39/13",
  "deckHref": "/decks/019dd923-5f69-752d-a9b5-a223ca1fad39",
  "deckJsonHref": "/decks/019dd923-5f69-752d-a9b5-a223ca1fad39.json",
  "deckAnchorHref": "/decks/019dd923-5f69-752d-a9b5-a223ca1fad39#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.85,
        "x": 0.12,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Portfolio growth by stage (Discovery, Preclinical, Clinical) from 2020-2024",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed711abe-8520-41a1-8dea-1fd7fc9ed231",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.38,
        "x": 0.31,
        "y": 0.26
      },
      "kind": "legend",
      "text": "Discovery, Preclinical Development, Clinical",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b39c6aef-5210-4342-a3b6-f0bfd55966b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Number of Programs",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-9d67-7119-9fe9-8d1f8ce16b47",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.17,
        "w": 0.67,
        "x": 0.038,
        "y": 0.048
      },
      "kind": "title",
      "text": "DG Portfolio: At tipping point to significant clinical expansion",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "700be7ff-33ea-4c77-8dce-e7f4ad93a09a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Small Multiples",
      "slug": "small-multiples",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "b3a7cc73-e7a1-4a33-af0b-7db624f1f65a",
      "evidence": "chart/bar-grouped: Portfolio growth by stage (Discovery, Preclinical, Clinical) from 2020-2024",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 15,
      "from": 10,
      "beatId": "d2eb4d8e-f2b5-4fb8-b808-68958b85be26",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "New Bliss",
      "beatSlug": "sparkline-new-bliss",
      "evidence": "Slides 10-15 showcase the potential of the AI Workbench and the ask for funding.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 2,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "4c35d279-9332-4853-a939-42653965f4a7",
      "evidence": "The deck implies that not using their technology would result in missed opportunities in drug discovery and development.",
      "position": 0,
      "objective": "Highlight the cost of not adopting Deep Genomics' technology",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 13,
      "from": 11,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "7286a8d1-e49e-412c-9849-a93fe3aff3bd",
      "evidence": "Slides 11-13 discuss the portfolio and potential for significant clinical expansion.",
      "position": 1,
      "objective": "Show the potential for quick wins and big bets with the AI Workbench",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}